Results 101 to 110 of about 11,119 (184)

A Randomized Factorial Trial of Varenicline, Nicotine Lozenges, and Smartphone Medication Adherence Reminders for Smoking Cessation: Protocol for the COMBO II Study. [PDF]

JMIR Res Protoc
Machado NM, Ahluwalia JS, Businelle MS, Frank-Pearce SG, Baranskaya I, Hébert ET, Sifat MS, Gwin SH, Thakur R, Glassman S, Kinnard HW, Kumar G, Gupta D, Kendzor DE.   +13 more
europepmc   +1 more source

Effects of Intensive Electroacupuncture on Nicotine Withdrawal and Withdrawal-Related Sleep Symptoms in Patients with Nicotine Dependence: A Three-Arm Randomized Controlled Trial. [PDF]

Ther Clin Risk Manag
Lai Z, Gao W, Yao X, Cao S, Xia X, Parry NA, Liang Y.   +6 more
europepmc   +1 more source

Differential effects of nAChR modulators on impulsive action in a nicotine self-administration Go/No-Go task in rats. [PDF]

Front Pharmacol
Chellian R, Huisman G, Caglayan L, Bruijnzeel AW.   +3 more
europepmc   +1 more source

Adverse Event Reporting Patterns of Tobacco Cessation Medications in Korea: A Disproportionality Analysis. [PDF]

Healthcare (Basel)
Min J, Cho E, Shin S, Choi YJ.
europepmc   +1 more source

Patient-Level Determinants Outweigh Pharmacotherapy Choice in Smoking Cessation: Evidence from a Real-World Study in Turkey. [PDF]

Healthcare (Basel)
Mutlu HH, Erdem F, Mutlu HH.
europepmc   +1 more source

Smoking Cessation Treatments Varenicline (Chantix®️), NRTs, and Nicotine Dependence

, 2019
Varenicline was approved in 2006 by the FDA as an effective smoking cessation drug. Varenicline was designed to bind with α4β2 nicotinic acetylcholine receptors (nAChR) to work as both an agonist and antagonist.
DeVoss, Marley Vea
core  

Vaping cessation interventions: A narrative review of randomized controlled trials. [PDF]

Tob Prev Cessat
Zolotarova T, Moiz A, Lelièvre A, Eisenberg MJ.   +3 more
europepmc   +1 more source

Neuropharmacology of Nicotine Addiction and Therapeutic Strategies for Smoking Cessation. [PDF]

Biology (Basel)
Hefny AA, Karuturi RC, Kalyaanamoorthy S, Rao PPN, Ganesan A.   +4 more
europepmc   +1 more source

The effectiveness and value of cytisinicline for smoking cessation: A summary from the institute for clinical and economic review's midwest comparative effectiveness public advisory council. [PDF]

J Manag Care Spec Pharm
Nikitin D, Tice JA, Suh K, Sanchez S, Richardson M, Phillips M, Carlson JJ, Chan HH, Rind DM, Agboola F.   +9 more
europepmc   +1 more source

Comparative Effectiveness of Cytisinicline and Varenicline for Smoking Cessation: A Matching-Adjusted Indirect Comparison (MAIC). [PDF]

J Health Econ Outcomes Res
Rubinstein M, Rowe D, Perdok R, Jacobs C.   +3 more
europepmc   +1 more source